Table 2.
Cancer therapy |
Number of studies [references] |
Total number of subjects |
Prevalence pre-treatment: mean (SE) [95% CI] |
Prevalence during treatment mean (SE) [95% CI] |
Prevalence post-treatment mean (SE) [95% CI] |
---|---|---|---|---|---|
All treatments | Seven [33, 34, 37, 39, 41–43] |
267 | 48.2% (0.09) [22.3–74.1] |
72.2% (0.05) [59.5–84.8] |
70.1% (0.01) [57.8–82.3] |
CT only | Four [34, 39, 41, 42] | 157 | 47.3% (0.16) [0–100] |
72.8% (0.09) [0–100] |
69.3% |
RT only | Three [33, 37, 43] | 110 | 50.0% (0.07) [0–100] |
74.5% (0.09) [34.1–100] |
71.4% |
CT + RT | Zero | 0 | NA | NA | NA |
CT chemotherapy, RT radiation therapy, SE standard error, CI confidence interval, NA not available